NCLN

NCLN (Nicalin) is an ER-resident transmembrane protein that serves as the organizing subunit of the Nicalin–NOMO–TMEM147 complex and, within the larger multipass translocon (MPT), facilitates the co-translational biogenesis of multi-pass membrane proteins at the ribosome–ER interface. Nicalin acts as the limiting factor for hierarchical assembly: it first stabilizes NOMO, then recruits TMEM147, and the resulting trimeric module integrates with Sec61, TMCO1, and CCDC47 to form the ~360 kDa ribosome-associated MPT, whose central membrane cavity accommodates transmembrane segment insertion of multi-pass clients such as EAAT1 (PMID:17261586, PMID:20538592, PMID:32820719). The MPT further associates substoichiometrically with PAT and TRAP complexes in a translation-dependent manner, with NOMO bridging Nicalin to TRAPα on the luminal side, and lipid-regulated SigmaR1 binding modulating translocon assembly at ER sheets (PMID:38866426, PMID:41476177). Beyond translocon function, the Nicalin–NOMO sub-complex antagonizes Nodal/TGFβ signaling during vertebrate mesendodermal patterning and participates in ER quality control by restricting surface delivery of misfolded transmembrane clients (PMID:15257293, PMID:24567339).

1. 2004 High

   Identification of Nicalin–NOMO as a signaling-modulatory complex established the first known function for NCLN: antagonism of Nodal/TGFβ signaling during vertebrate embryonic patterning.

   Evidence Ectopic expression in zebrafish embryos, Nodal/Activin reporter assays, co-immunoprecipitation, and morpholino knockdown

   PMID:15257293

   Open questions at the time

   • Mechanism by which the complex inhibits Nodal signaling (receptor binding, ligand sequestration, or indirect) was not resolved
   • Whether Nicalin functions independently of NOMO in signaling was not tested
2. 2007 Medium

   Demonstration that Nicalin is the limiting factor controlling NOMO stability revealed the hierarchical logic of complex assembly, explaining how stoichiometry of the complex is regulated post-transcriptionally.

   Evidence RNAi knockdown and overexpression with western blot quantification of NOMO protein levels

   PMID:17261586

   Open questions at the time

   • The structural basis for Nicalin-dependent NOMO stabilization was unknown
   • Whether additional obligate partners existed was not addressed
3. 2010 High

   Discovery of TMEM147 as a third obligate subunit redefined the Nicalin–NOMO complex as a trimeric ER-resident assembly and extended the hierarchical stabilization model to a third component.

   Evidence Affinity purification/mass spectrometry identification with RNAi and overexpression validation

   PMID:20538592

   Open questions at the time

   • Functional contribution of TMEM147 beyond complex membership was not defined
   • Cellular clients of the trimeric complex were unknown
4. 2014 Medium

   Two studies broadened NCLN function beyond signaling: the C. elegans ortholog NRA-2 was shown to act as an ER quality control factor retaining hyperactivated DEG/ENaC channels, and mammalian Nicalin was found associated with AMPA receptor trafficking complexes in neurons.

   Evidence C. elegans knockout genetics, Xenopus oocyte electrophysiology, ganglioside affinity capture/quantitative proteomics in rat neurons

   PMID:24567339 PMID:25253868

   Open questions at the time

   • Whether ER retention of channels is a conserved function in mammals was not established
   • Direct physical interaction between Nicalin and AMPA receptor subunits was not confirmed by reciprocal methods
   • The relationship between quality control and signaling functions was unclear
5. 2017 Medium

   Zebrafish CRISPR knockouts linked Nicalin to enteric nervous system development, expanding its in vivo relevance to neuronal migration and differentiation in the gut.

   Evidence Morpholino knockdown and CRISPR knockout in zebrafish with ENS phenotyping

   PMID:28274275

   Open questions at the time

   • Whether the ENS phenotype reflects Nodal signaling antagonism, translocon function, or both was not resolved
   • Human disease association was identified by exome sequencing but not functionally validated
6. 2020 High

   Cryo-EM structure of the multipass translocon revealed that the Nicalin–NOMO–TMEM147 trimeric module is a core component of the ribosome-associated MPT, redefining Nicalin's primary molecular role as a co-translational insertase accessory subunit for multi-pass membrane proteins.

   Evidence Cryo-EM at the ribosome exit tunnel, ribosome profiling/mRNA sequencing of MPT-engaged transcripts, EAAT1 client loss in knockout cells

   PMID:32820719

   Open questions at the time

   • Specific contributions of Nicalin versus TMEM147 versus NOMO within the MPT were not delineated
   • How the MPT selects multi-pass over single-pass clients was mechanistically unexplained
7. 2024 Medium

   Cryo-electron tomography in native ER membranes showed substoichiometric, translation-dependent association of the MPT with PAT and TRAP complexes, and AlphaFold modeling proposed that NOMO bridges Nicalin to TRAPα, delineating luminal architecture of the expanded translocon.

   Evidence Cryo-ET with subtomogram averaging in native membranes, AlphaFold structural prediction

   PMID:38866426

   Open questions at the time

   • The NOMO–TRAPα bridging interaction relies on AlphaFold prediction and lacks direct experimental validation (e.g., cross-linking or mutagenesis)
   • Functional consequences of PAT/TRAP association for client biogenesis were not tested
8. 2025 Medium

   Identification of SigmaR1 as a lipid-regulated interactor of Nicalin introduced a phosphatidylcholine-dependent regulatory layer to translocon assembly at ER sheets.

   Evidence Endogenous tagging, co-immunoprecipitation, lipid-binding biochemistry in cell fractionation

   PMID:41476177

   Open questions at the time

   • Whether SigmaR1 binding modulates MPT client handling or selectivity is untested
   • Structural basis of the SigmaR1–Nicalin interface is unresolved

• Key unresolved questions include how Nicalin's translocon role relates to its Nodal signaling antagonism, the structural basis for multi-pass client selectivity by the MPT, and whether Nicalin dysfunction causes human disease.
• No human Mendelian disease directly attributed to NCLN mutations with functional validation
• Mechanistic link between MPT function and Nodal signaling antagonism is unknown
• No reconstituted in vitro system for MPT-mediated insertion of multi-pass clients exists